CADx gets US nod for two new Second Look products:
This article was originally published in Clinica
CADx Systems has received US FDA approval for two new computer-aided detection (CAD) systems for use with mammography. The Second Look Digital is aimed purely at highlighting suspicious areas on images taken using digital mammography, whilst the Second Look AD is a hybrid system able to analyse both traditional film-based or digital images. The approval allows both systems to process images from GE Medical Systems' Senographe 2000D full field digital mammography system. The Beavercreek, Ohio firm told Clinica it is also working on getting approval for integration of the products with imaging systems made by Fischer Imaging and Hologic. The new CAD systems complement the firm's Second Look CAD for film-based mammography, which is already on the market.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.